BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lowered its stake in shares of Mylan (NASDAQ:MYL) by 59.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 164,356 shares of the company’s stock after selling 244,830 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Mylan were worth $5,156,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. AMP Capital Investors Ltd raised its position in shares of Mylan by 82.0% during the 3rd quarter. AMP Capital Investors Ltd now owns 642,574 shares of the company’s stock valued at $20,158,000 after buying an additional 289,485 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in shares of Mylan by 6.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 68,557 shares of the company’s stock valued at $2,150,000 after purchasing an additional 4,277 shares during the last quarter. Partners Capital Investment Group Holdings LLC bought a new position in shares of Mylan during the 3rd quarter valued at $642,000. Engineers Gate Manager LP grew its holdings in shares of Mylan by 90.0% during the 3rd quarter. Engineers Gate Manager LP now owns 57,136 shares of the company’s stock valued at $1,792,000 after purchasing an additional 27,071 shares during the last quarter. Finally, Synovus Financial Corp grew its holdings in shares of Mylan by 25.4% during the 3rd quarter. Synovus Financial Corp now owns 28,876 shares of the company’s stock valued at $907,000 after purchasing an additional 5,858 shares during the last quarter. Hedge funds and other institutional investors own 75.04% of the company’s stock.

Several research firms recently commented on MYL. Guggenheim began coverage on shares of Mylan in a report on Tuesday. They set a “buy” rating and a $59.00 target price on the stock. Mizuho reaffirmed a “buy” rating and set a $37.00 target price on shares of Mylan in a report on Tuesday, October 24th. BidaskClub raised shares of Mylan from a “hold” rating to a “buy” rating in a report on Friday, October 27th. Royal Bank of Canada set a $32.00 target price on shares of Mylan and gave the company a “hold” rating in a report on Friday, October 20th. Finally, J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $48.00 target price (up previously from $44.00) on shares of Mylan in a report on Friday, October 6th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and fourteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $42.41.

Shares of Mylan (NASDAQ:MYL) opened at $39.53 on Thursday. The stock has a market cap of $21,183.87, a price-to-earnings ratio of 8.40, a price-to-earnings-growth ratio of 2.16 and a beta of 1.38. Mylan has a twelve month low of $29.39 and a twelve month high of $45.87. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.46 and a quick ratio of 0.95.

Mylan (NASDAQ:MYL) last announced its quarterly earnings results on Monday, November 6th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.10). The firm had revenue of $2.99 billion during the quarter, compared to the consensus estimate of $3.09 billion. Mylan had a return on equity of 20.63% and a net margin of 7.28%. Mylan’s revenue was down 2.3% on a year-over-year basis. During the same period last year, the business earned $1.38 EPS. equities analysts expect that Mylan will post 4.56 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Lowers Stake in Mylan (MYL)” was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/british-columbia-investment-management-corp-lowers-stake-in-mylan-myl/1762882.html.

About Mylan

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.